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Abstract
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Dizocilpine maleate (MK-801) is one of several NMDA receptor antagonists that is widely used to
pharmacologically model the symptoms of psychosis and schizophrenia in animals. MK-801
elicits behaviors in adult zebrafish (Danio rerio) that are phenotypically consistent with behaviors
observed in humans and rodents exposed to tbhe drug. However, the molecular and cellular
processes that mediate the psychotomimetic, cognitive and locomotive behaviors of MK-801 are
unclear. We exposed zebrafish larvae to MK-801 to assess their merit as a model organism to
elucidate the behavioral effects of NMDA receptor blockade. Zebrafish larvae were acutely
immersed in MK-801 to assess the effect on spontaneous swimming. MK-801 caused a time- and
dose-dependent increase in larval swim speed, and the peak response (a five-fold increase in swim
speed) was evoked by a three h exposure to a 20 uM dose. Zebrafish larvae did not exhibit
sensitivity to the locomotor effects of MK-801 until 5 dpf, suggesting a critical role for
developmental in sensitivity to the drug. Exposure to the low potency NMDA antagonist,
memantine, did not alter the swim speed of zebrafish larvae. Co-immersion in D1 or D2 dopamine
receptor antagonists did not disrupt the time course or magnitude of the increase in swim speed,
suggesting dopaminergic signaling is not required for the locomotor actions of MK-801. Our
findings of the behavioral actions of MK-801 in zebrafish larvae are consistent with previous
observations in mammals and imply that the physiological, cellular and molecular processes
disrupted by MK-801 are conserved in zebrafish larvae. These data suggest that the zebrafish
larvae is a valid and useful model to elucidate neurobehavioral aspects of NMDA receptor
antagonism and may provide insight to the neurobiology of psychosis and schizophrenia.
N-methyl-D-aspartate (NMDA) receptors are a subclass of ionotropic glutamate receptor
that mediate excitatory transmission throughout the central nervous system (Dingledine,
Borges, Bowie, & Traynelis, 1999). Pharmacological blockade of NMDA receptors with
dissociative anesthetics like PCP and ketamine exacerbate the symptoms of schizophrenia
and evoke a myriad of schizophreniform behaviors in healthy humans that are isomorphic
with the idiopathic disease (Javitt & Zukin, 1991; Luby, Cohen, Rosenbaum, Gottleib, &
Kelley, 1959). Stimulants such as cocaine and amphetamine can also induce schizophrenialike symptoms (Ellinwood, Sudilovsky, & Nelson, 1973), but the spectrum of symptoms
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induced by NMDA receptor antagonists more fully recapitulate the positive, negative, and
cognitive symptoms of schizophrenia (Krystal et al., 1994).
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NMDA receptor antagonists are used extensively to model schizophrenia in rodents (Coyle,
Tsai, & Goff, 2003; Javitt, 2004; Jentsch & Roth, 1999). Animal models of schizophrenia
are useful for drug screening, but they can also provide insight to the pathophysiology of the
disease. MK-801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine
maleate)] is a potent PCP congener (Wong, Kemp, Priestly, Knight, Woodruff, & Iversen,
1986) that blocks NMDA receptors and reproduces most symptoms of schizophrenia (Javitt
& Zukin, 1991), including pronounced psychomotor disturbances like head twitching, and
head weaving (Breese, Knapp, & Moy, 2002; Gilmour et al., 2009).
There is compelling evidence that the behavioral, locomotor and cognitive actions of
MK-801 are retained in adult zebrafish since the drug disrupts shoaling behavior
(Echevarria, Hammack, Pratt, & Hosemann, 2008), increases circling and swimming
behavior and decreases performance in conditioned place preference experiments (Swain,
Sigstad, & Scalzo, 2004).
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Zebrafish possess several inherent advantages to elucidate the behavioral and molecular
neuropharmacology of NMDA receptor blockade, including a high fecundity, physiological
similarity to mammals, adaptability to multiple experimental techniques, and an amenability
to high throughput approaches and forward genetic screens (Pyati, Look, &
Hammerschmidt, 2007). MK-801 was recently shown to disrupt respiratory physiology in
zebrafish larvae (Turesson, Schwerte, & Sundin, 2006), but the psychomotor actions of
MK-801 have not been characterized in zebrafish larvae. We therefore set out to
characterize the behavioral pharmacology of MK-801-evoked locomotion in zebrafish
larvae.

Method
Subjects
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A breeding stock of 20 adult wild type zebrafish (AB strain) was purchased from Zebrafish
International Resource Center (Eugene, OR). Male and female fish were housed together in
two 20 L aquaria supplied with fish water at 28° C, pH 8.0 and a conductivity of 500 μS.
Aeration and filtration was provided by a canister filter system (XP4, RENA www.rena.fr).
Adult fish were kept on a 14 h light, 10 h dark photoperiod and fed a mixture of dry brine
shrimp flakes (Brine Shrimp Direct, Ogden, UT) and live brine shrimp (Artemia nauplii)
three times per day. Fish were acclimated to laboratory conditions for 30 days prior to
breeding.
Zebrafish embryos were obtained by natural, pair-wise mating (Westerfield, 1993). Embryos
were collected 4 hours post fertilization (hpf), cleaned, sorted and stored in buffered embryo
media: 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2 and 0.33 mM MgSO4 at 28.5 °C.
At 1-day post fertilization (dpf), zebrafish embryos were treated with a 0.1mg/ml protease
solution (P6911; Sigma Aldrich, St Louis, MO) to digest the chorion. After digestion of the
chorion, embryos were washed in embryo media and stored in the dark at 28.5 °C until time
of experiment. All procedures were approved by Institutional Animal Care and Use
Committee (IACUC), Charles Drew University.
General procedure
Zebrafish were digitally video recorded to assess the behavioral effects of acute exposure to
MK-801 on spontaneous (fictive) locomotion. Slight differences in the early development of
Int J Comp Psychol. Author manuscript; available in PMC 2011 January 26.
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zebrafish larvae can impact locomotor capacity (Kimmel, Patterson, & Kimmel, 1974), so
larvae were arranged into groups of ten to minimize the impact of individual variance in
locomotor response to drugs. Data points, therefore, represent an average response of groups
of larvae rather than an average response of individual larvae.
Locomotion assay
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On the day of experimentation, zebrafish larvae were arranged into groups of 10 and
transferred to the wells of a 12-well multiplate (diameter = 22 mm). For visualization and
video recording, multiwell plates were placed atop a light box (PortaTrace, Gagne,
Inc.;Johnson City, NY, USA) for illumination. Since changes in illumination can evoke
transient changes in activity (Burgess & Granato, 2007a), zebrafish were exposed to
continuous illumination for at least 10 min prior to recordings. The spontaneous locomotor
activity of each group of animals was recorded by a digital video camera suspended above
the set up which captured video at a frame rate of 30 frames per second (Sanyo Xacti, Sanyo
North America, San Diego, CA). This experimental set up only captures displacement in the
X- and Y- planes, so larvae were suspended in a minimal volume (2.0 mL) throughout this
study to minimize the depth of the liquid (∼5 mm) and restrict locomotion in the z-axis.
Physical stimuli can also evoke locomotor responses in zebrafish larvae (Ribera & NussleinVolhard, 1998), so larvae were left undisturbed for at least 10 min prior to video recording.
The activity of each group of larvae was video recorded for five min to capture basal
locomotor activity. The media in each well was then replaced with 2.0 mL of drugsupplemented media (experimental groups) or vehicle-supplemented media (control groups).
Subsequent video recordings were obtained either hourly or after 4 h of exposure to monitor
drug-induced changes in locomotion. All drugs were purchased from Tocris Bioscience
(Ellisville, MO).
Locomotor analysis
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Native digital video files (MPEG-4) were transferred to a personal computer and
reformatted to MPEG-1 format with IMTOO MPEG converter software (www.imtoo.com).
The behavioral analysis software package, GroupScan 1.00 (Clever Sys, Renton, VA), was
used to calculate the average locomotor speed (mm/sec) for the group of larvae. The
locomotor activity was measured as the average swim speed of larvae housed in the wells of
a 12 well, multi-well plate. Data were exported to SigmaPlot 10.0 (Systat Software, San
Jose, CA) for plotting, analyses of variance (ANOVA) and Tukey's test. Statistical
significance was set at p < 0.05. Each point represents the mean ± SEM (n = 4-8). Changes
in locomotor activity (Δ locomotor activity) were calculated by subtracting the average
speed obtained prior to drug exposure (t = 0 h) from the average speed obtained after a given
period of drug exposure.

Results
The zebrafish nervous system is sufficiently developed by 5 dpf to permit free swimming
larvae to interact with the environment (Budick & O'Malley, 2000; Kimmel, Ballard,
Kimmel, Ullmann, & Schilling, 1995). Our initial characterization of the locomotor effect of
MK-801 was therefore performed with 5 dpf larvae. Immersion in 50 uM MK-801 increased
the spontaneous locomotion of zebrafish larvae as early as 1 h after exposure. The average
swim speed of zebrafish larvae immersed in MK-801 increased nearly five-fold, from 0.44 ±
0.31 mm/sec (mean ± SEM) to 1.97 ± 0.20 mm/sec (p < 0.05) (Fig. 1). The increase in swim
speed was time-dependent and the response peaked after 3 h of exposure. The gain in swim
speed persisted for the course of the experiment. All subsequent video recordings were
obtained after 4 h of exposure to drugs to ensure the maximal behavioral response was
captured.
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The locomotor response to MK-801 was dose-dependent. A 5 μM dose of MK-801 elicited a
statistically significant increase in spontaneous locomotion of 0.29 ± 0.7 mm/sec (p < 0.05).
The maximal increase in average swim speed, 1.35 ± 0.13 mm/sec, was evoked by a 20 μM
dose of MK-801 (Fig. 2). Higher doses evoked smaller increases in swim speed and
conferred an “inverted U” shape to the dose-response curve. The EC50 for the increase in
swim speed was 10.3 μM.
Memantine is a low potency NMDA receptor antagonist that evokes a minimal locomotor
response in mammals when administered at very high doses (Gilmour et al., 2009).
Memantine did not increase the swim speed of zebrafish larvae at any dose tested (Fig. 3),
including a 500 μM dose (data not shown).
Rodents display locomotor responses to MK-801 as early as postnatal day 3 or 4
(Rajachandran, Goodwin, & Spear, 1991). In our study, zebrafish larvae were exposed to
MK-801 on dpf 2-7 to characterize the development of behavioral sensitivity to the drug.
Developmental age was vital for the locomotor response to MK-801 as locomotor responses
could only be evoked from zebrafish larvae older than 5 dpf (Fig. 4). Interestingly, the
amplitude of the locomotor response to MK-801 was not developmentally-sensitive since
the magnitude of the gain in swim speed was equivalent among larvae aged 5, 6, or 7 dpf
(Fig. 4).
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In mammals, the behavioral actions of psychomotor stimulants are mediated mostly by
disruptions in dopamine signaling. MK-801, however, is unique since an dopamine
signaling is not required for the locomotor actions of the drug (Chartoff, Heusner, &
Palmiter, 2005; Mele, Cabib, & Oliviero, 1995; Okuyama, Imagawa, & Tomigawa, 1996).
The role of dopamine in the psychomotor actions of MK-801 has not been characterized in
zebrafish. We therefore exposed zebrafish larvae to MK-801 solutions supplemented with a
D1 dopamine receptor antagonist (SKF-83566) (Arnt & Hyttel, 1986) or a D2 dopamine
receptor antagonist (sulpiride) (Usuda, Nishikori, Noshiro, & Maeno, 1981) to determine the
role of dopamine in MK-801-evoked locomotion.
Concurrent exposure to dopamine receptor antagonists, SKF-83566 and sulpiride, either
alone or together, did not attenuate the locomotor response to MK-801 (Fig. 5). This
suggests that neither D1–like nor D2–like dopamine receptor activation is required.

Discussion
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This study demonstrates that the neurobehavioral actions NMDA receptor antagonism are
conserved in zebrafish larvae, and that our findings are qualitatively comparable to findings
previously described in rodents (Loscher & Honack, 1992) and adult zebrafish (Swain et al.,
2004). For example, acute MK-801 exposure elicits robust response in both fish and rodent
models, but the low potency antagonist, memantine, does not evoke a locomotor response in
either species (see Fig. 3 and Gilmour et al., 2009). The EC50 of the locomotor response to
MK-801 in zebrafish larvae is 10 uM, a value that is consistent with the EC50 of MK-801evoked behaviors previously described in adult zebrafish (Echevarria et al., 2008; Swain et
al., 2004) and rodents (Gilmour et al., 2009). Interestingly, the locomotor actions of MK-801
are dose-dependent and biphasic in both rodents and fish; low concentrations are stimulatory
while high concentrations of the drug are are sedating. In mammals, dopamine is not
required to elicit the psychomotor effects of MK-801 (Chartoff et al., 2005). To our
knowledge the role of dopamine in the zebrafish response to MK-801 has not previously
been described. In this study we demonstrate that consistent with findings in mammalian
models, dopamine is not required for the locomotor actions of MK-801 in zebrafish larvae
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Our data demonstrate several similarities between the MK-801-evoked behaviors of
mammals and fish, however, some differences were observed.
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For example, MK-801 evokes locomotor responses in neonatal rats as early as postnatal day
3 (Rajachandran et al., 1991), but larval zebrafish did not respond to the drug until 5 dpf
(Fig. 3). This was a very curious finding since zebrafish larvae respond to tactile stimuli as
early as 27 hpf (Ribera & Nusslein-Volhard, 1998) and mRNA transcripts for NMDA
receptor subunits are detected as early as 24 hpf (Cox, Kucenas, & Voigt, 2005). However,
our data are consistent with a previous report which demonstrated that MK-801 does not
evoke physiological changes in zebrafish respiration until 6 dpf (Turesson et al., 2006).
These data imply that the glutamatergic circuits responsible for the behavioral and
physiological actions of MK-801 are not active until after 5 dpf.
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Prepulse inhibition (PPI) is a sensorimotor gating mechanism in which a weaker prestimulus
(prepulse) inhibits the reaction of an organism to a subsequent strong, startling stimulus
(pulse). Sensorimtor gating deficits are a hallmark of schizophrenia and are frequently used
as diagnostic tools in clinical and preclinical investigations (Bloom & Kupfer, 1995). PPI
involves glutamatergic pathways and PCP and MK-801 have both been shown to disrupt it
(Geyer, 1998). Since PPI has been demonstrated in zebrafish larvae as early as 3 dpf
(Burgess & Granato, 2007b), it might be insightful to assess the effects of MK-801 on PPI in
3 or 4 dpf zebrafish larvae. Such an investigation may help distinguish the glutamatergic
circuits that modulate PPI from those that mediate the locomotor actions of MK-801.
Overall, the behavioral and pharmacological data presented in this report demonstrate the
considerable phenotypic similarities in MK-801-induced behaviors of mammals and
zebrafish. We interpret these results to suggest a high degree of conservation in the
underlying cellular and molecular mechanisms that mediate MK-801-evoked behaviors.
Since the psychomotor actions of MK-801 actions are not completely understood (Breese et
al., 2002) we propose that the zebrafish larvae is a highly suitable model to elucidate
fundamental aspects of psychomotor stimulants.
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Figure 1.

Temporal effects of MK-801 on locomotor activity of zebrafish larvae. Results are presented
as means + S.E.M. N = 4 groups of larvae per condition, F(5, 12) = 5.60, p = 0.0068, *vs 0h,
p < 0.05 by Tukey's HSD).
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Figure 2.
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Dose-dependency of the locomotor effect of MK-801. Changes in spontaneous locomotion
(Δ spontaneous locomotion) were calculated by (AVG Speed at t4h − AVG Speed at t0h) at
each dose. Values are presented as means ± S.E.M. Dashed line represents a non-linear
regression of the data (Sigma Plot 10); calculated EC50 = 10.3μM; R2 = 0.9917. N = 4-8
groups of larvae per concentration, F(5, 18) = 8.00. p = 0.0004, *dose vs vehicle (0 μM), p <
0.05 by Tukey's HSD).
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Figure 3.

Effect of memantine on spontaneous locomotion of zebrafish larvae. Changes in
spontaneous locomotion (Δ spontaneous locomotion) were calculated by (AVG Speed at t4h
– AVG Speed at t0h) at each dose. Values are presented as means ± S.E.M. N = 4 groups of
larvae per concentration [F(5, 18) = 0.30, p = 0.91].
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Figure 4.
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Effect of development on sensitivity to locomotor effects of MK-801. Changes in
spontaneous locomotion (Δ spontaneous locomotion) were calculated by (AVG Speed at t4h
– AVG Speed at t0h) at the developmental times indicated. Values are presented as means +
S.E.M. N = 4-8 groups of larvae per concentration, F(5, 18) = 6.88. p = 0.0002, *Control vs
50 μm MK, p < 0.05 by Tukey's HSD).
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Figure 5.

Effect of dopamine receptor antagonists on the locomotor effects of MK-801. Groups of
zebrafish larvae (5dpf) were concurrently exposed to 50 μM MK-801 + 50 μM Sulpiride; 50
μM MK-801 + 50 μM SKF-83566; or 50 μM MK-801 + 50 μM Sulpiride + 50 μM
SKF-83566. Dashed line represents the time course of the locomotor response to 50 μM
MK-801 shown in Fig. 1 for compairson. Values are presented as means + S.E.M. N = 4
groups of aniamls per drug combination [F(5, 18) = 14.27. p = 0.0001].
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